CD38 and macrophage activation syndrome: These data support a role for IFN-I and IL-15 in promoting the differentiation of CD38+ HLA-DR+ T and NK cells and illustrate the potential utility of JAK inhibitors and possibly mTOR inhibitors to control the expansion of these cells in MAS.